News
AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...
15h
GlobalData on MSNAstraZeneca’s amyloidosis drug fails to impress in Phase IIIAstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials. A ...
Groundbreaking findings from Malaysia’s Heart2Miss heart failure screening programme were presented at the European Society ...
18h
Vietnam Investment Review on MSNAstraZeneca Vietnam retains spot in 2025 top 50 Corporate Sustainability AwardsAstraZeneca Vietnam has been honoured in the Outstanding CSR Activities category at the 2025 Top 50 Corporate Sustainability ...
In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...
10h
Zacks Investment Research on MSNAstraZeneca's AL Amyloidosis Drug Misses Goal in Late-Stage StudiesAstraZeneca AZN reported disappointing results from two late-stage studies that evaluated its investigational light chain ...
New class of Eureka Fellows selected for their outstanding efforts to build a healthier, more equitable world and will receive support to amplify their sustainability impact in Canada and around ...
In recent years successive governments have sought to close down free speech. If we are to avoid the enslavement of our ...
Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...
Stock markets ended lower on Thursday because IT stocks were sold off and investors were cautious ahead of the results from ...
DelveInsight's Type 1 Diabetes pipeline report depicts a robust space with 85+ active players working to develop 100+ ...
The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives; namely, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results